South Korea Crispr And Cas Genes Market Size & Outlook
South Korea crispr and cas genes market, 2018-2030 (US$M)
Related Markets
South Korea crispr and cas genes market highlights
- The South Korea crispr and cas genes market generated a revenue of USD 56.7 million in 2023 and is expected to reach USD 181.7 million by 2030.
- The South Korea market is expected to grow at a CAGR of 18.1% from 2024 to 2030.
- In terms of segment, product was the largest revenue generating product & service in 2023.
- Service is the most lucrative product & service segment registering the fastest growth during the forecast period.
Crispr and cas genes market data book summary
| Market revenue in 2023 | USD 56.7 million |
| Market revenue in 2030 | USD 181.7 million |
| Growth rate | 18.1% (CAGR from 2023 to 2030) |
| Largest segment | Product |
| Fastest growing segment | Service |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Product, Service |
| Key market players worldwide | AstraZeneca PLC, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, CRISPR Therapeutics AG, Editas Medicine Inc, Roche Holding AG, PerkinElmer, Genscript Biotech Corp Class H, Danaher Corp, Intellia Therapeutics Inc, Lonza Group Ltd, Merck KGaA, Takara Bio Inc, Thermo Fisher Scientific Inc, Cibus Inc Ordinary Shares - Class A, Beam Therapeutics Inc, Vertex Pharmaceuticals Inc, Addgene, EGenesis, Synthego, Mammoth Biosciences, Inscripta, PLANTEDIT, Hera Biotech, Origene Technologies, Recombinetics |
Other key industry trends
- In terms of revenue, South Korea accounted for 1.8% of the global crispr and cas genes market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China crispr and cas genes market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 421.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
CRISPR And Cas Genes Market Scope
CRISPR And Cas Genes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Korea crispr and cas genes market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to crispr and cas genes market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 78.48% in 2023. Horizon Databook has segmented the South Korea crispr and cas genes market based on product, service covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea’s CRISPR market is expected to be driven by strategic developments of local players. Tool Gen, Inc., one of the major players in South Korea’s CRISPR market, has undertaken multiple licensing agreements and collaborations with international companies to expand the use of its CRISPR/Cas9 technologies.
For instance, in August 2019, Tool Gen collaborated with Viva Zome Therapeutics Pty Ltd., a privately held Australian biotech company, to explore gene editing of cells for improved production of exosome s. Tool Gen employed its CRISPR/Cas9 technology to develop gene edits into selected cell types, which were further analyzed by Viva Zone.
In August 2017, Tool Gen and Monsanto Company, a U.S.-based firm, entered into a licensing agreement, under which the former’s CRISPR technology platform was utilized for development of agricultural products.
Reasons to subscribe to South Korea crispr and cas genes market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Korea crispr and cas genes market databook
-
Our clientele includes a mix of crispr and cas genes market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea crispr and cas genes market , including forecasts for subscribers. This country databook contains high-level insights into South Korea crispr and cas genes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Korea crispr and cas genes market size, by product & service, 2018-2030 (US$M)
South Korea CRISPR And Cas Genes Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
